Comparison of serum cystatin C and creatinine changes after cardiopulmonary bypass in patients with normal preoperative kidney function

Anders S. Svensson, Csaba Kovesdy, John Peder Escobar Kvitting, Magnus Rosén, Ingemar Cederholm, Zoltán Szabó

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Purpose: Serum creatinine is used ubiquitously to estimate glomerular filtration rate and to diagnose acute kidney injury after cardiac surgery. Serum cystatin C is a novel biomarker that has emerged as a possible diagnostic alternative to serum creatinine. It is unclear if the dynamic changes in serum cystatin C immediately following cardiopulmonary bypass (CPB) differ from those of serum creatinine in patients with normal preoperative kidney function. Methods: We compared changes in serum levels of creatinine and cystatin C by measuring them serially in 19 patients undergoing CPB. Within-patient differences for serum creatinine and serum cystatin C were compared by repeated measures ANOVA. Results: Serum creatinine and cystatin C levels showed significant correlation with each other. Both biomarkers showed a significant decrease after CPB, but their serum concentrations reverted to pre-CPB levels within 12 h. Serum levels of serum creatinine remained unchanged from baseline levels throughout 72-h post-CPB. In contrast, serum cystatin C levels rose further and became significantly higher compared to baseline within 48 h. Serum cystatin C remained significantly elevated at 48- and 72-h post-CPB. Conclusions: Processes that determine the serum concentrations of serum creatinine and cystatin C in the post-CPB period affect the two biomarkers differently, suggesting that the two are not interchangeable as diagnostic markers of glomerular filtration rate. Future studies are needed to examine if these discrepancies are related to differences in their production rates, in their ability to detect small changes in glomerular filtration rate, or to a combination of these, and to determine the effect of such differences on the diagnostic and prognostic accuracy of the two biomarkers.

Original languageEnglish (US)
Pages (from-to)1597-1603
Number of pages7
JournalInternational Urology and Nephrology
Volume45
Issue number6
DOIs
StatePublished - Dec 1 2013

Fingerprint

Cystatin C
Cardiopulmonary Bypass
Creatinine
Kidney
Serum
Biomarkers
Glomerular Filtration Rate

All Science Journal Classification (ASJC) codes

  • Nephrology
  • Urology

Cite this

Comparison of serum cystatin C and creatinine changes after cardiopulmonary bypass in patients with normal preoperative kidney function. / Svensson, Anders S.; Kovesdy, Csaba; Kvitting, John Peder Escobar; Rosén, Magnus; Cederholm, Ingemar; Szabó, Zoltán.

In: International Urology and Nephrology, Vol. 45, No. 6, 01.12.2013, p. 1597-1603.

Research output: Contribution to journalArticle

Svensson, Anders S. ; Kovesdy, Csaba ; Kvitting, John Peder Escobar ; Rosén, Magnus ; Cederholm, Ingemar ; Szabó, Zoltán. / Comparison of serum cystatin C and creatinine changes after cardiopulmonary bypass in patients with normal preoperative kidney function. In: International Urology and Nephrology. 2013 ; Vol. 45, No. 6. pp. 1597-1603.
@article{87058c50008148559f1c25f26f6fd10a,
title = "Comparison of serum cystatin C and creatinine changes after cardiopulmonary bypass in patients with normal preoperative kidney function",
abstract = "Purpose: Serum creatinine is used ubiquitously to estimate glomerular filtration rate and to diagnose acute kidney injury after cardiac surgery. Serum cystatin C is a novel biomarker that has emerged as a possible diagnostic alternative to serum creatinine. It is unclear if the dynamic changes in serum cystatin C immediately following cardiopulmonary bypass (CPB) differ from those of serum creatinine in patients with normal preoperative kidney function. Methods: We compared changes in serum levels of creatinine and cystatin C by measuring them serially in 19 patients undergoing CPB. Within-patient differences for serum creatinine and serum cystatin C were compared by repeated measures ANOVA. Results: Serum creatinine and cystatin C levels showed significant correlation with each other. Both biomarkers showed a significant decrease after CPB, but their serum concentrations reverted to pre-CPB levels within 12 h. Serum levels of serum creatinine remained unchanged from baseline levels throughout 72-h post-CPB. In contrast, serum cystatin C levels rose further and became significantly higher compared to baseline within 48 h. Serum cystatin C remained significantly elevated at 48- and 72-h post-CPB. Conclusions: Processes that determine the serum concentrations of serum creatinine and cystatin C in the post-CPB period affect the two biomarkers differently, suggesting that the two are not interchangeable as diagnostic markers of glomerular filtration rate. Future studies are needed to examine if these discrepancies are related to differences in their production rates, in their ability to detect small changes in glomerular filtration rate, or to a combination of these, and to determine the effect of such differences on the diagnostic and prognostic accuracy of the two biomarkers.",
author = "Svensson, {Anders S.} and Csaba Kovesdy and Kvitting, {John Peder Escobar} and Magnus Ros{\'e}n and Ingemar Cederholm and Zolt{\'a}n Szab{\'o}",
year = "2013",
month = "12",
day = "1",
doi = "10.1007/s11255-013-0403-5",
language = "English (US)",
volume = "45",
pages = "1597--1603",
journal = "International Urology and Nephrology",
issn = "0301-1623",
publisher = "Springer Netherlands",
number = "6",

}

TY - JOUR

T1 - Comparison of serum cystatin C and creatinine changes after cardiopulmonary bypass in patients with normal preoperative kidney function

AU - Svensson, Anders S.

AU - Kovesdy, Csaba

AU - Kvitting, John Peder Escobar

AU - Rosén, Magnus

AU - Cederholm, Ingemar

AU - Szabó, Zoltán

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Purpose: Serum creatinine is used ubiquitously to estimate glomerular filtration rate and to diagnose acute kidney injury after cardiac surgery. Serum cystatin C is a novel biomarker that has emerged as a possible diagnostic alternative to serum creatinine. It is unclear if the dynamic changes in serum cystatin C immediately following cardiopulmonary bypass (CPB) differ from those of serum creatinine in patients with normal preoperative kidney function. Methods: We compared changes in serum levels of creatinine and cystatin C by measuring them serially in 19 patients undergoing CPB. Within-patient differences for serum creatinine and serum cystatin C were compared by repeated measures ANOVA. Results: Serum creatinine and cystatin C levels showed significant correlation with each other. Both biomarkers showed a significant decrease after CPB, but their serum concentrations reverted to pre-CPB levels within 12 h. Serum levels of serum creatinine remained unchanged from baseline levels throughout 72-h post-CPB. In contrast, serum cystatin C levels rose further and became significantly higher compared to baseline within 48 h. Serum cystatin C remained significantly elevated at 48- and 72-h post-CPB. Conclusions: Processes that determine the serum concentrations of serum creatinine and cystatin C in the post-CPB period affect the two biomarkers differently, suggesting that the two are not interchangeable as diagnostic markers of glomerular filtration rate. Future studies are needed to examine if these discrepancies are related to differences in their production rates, in their ability to detect small changes in glomerular filtration rate, or to a combination of these, and to determine the effect of such differences on the diagnostic and prognostic accuracy of the two biomarkers.

AB - Purpose: Serum creatinine is used ubiquitously to estimate glomerular filtration rate and to diagnose acute kidney injury after cardiac surgery. Serum cystatin C is a novel biomarker that has emerged as a possible diagnostic alternative to serum creatinine. It is unclear if the dynamic changes in serum cystatin C immediately following cardiopulmonary bypass (CPB) differ from those of serum creatinine in patients with normal preoperative kidney function. Methods: We compared changes in serum levels of creatinine and cystatin C by measuring them serially in 19 patients undergoing CPB. Within-patient differences for serum creatinine and serum cystatin C were compared by repeated measures ANOVA. Results: Serum creatinine and cystatin C levels showed significant correlation with each other. Both biomarkers showed a significant decrease after CPB, but their serum concentrations reverted to pre-CPB levels within 12 h. Serum levels of serum creatinine remained unchanged from baseline levels throughout 72-h post-CPB. In contrast, serum cystatin C levels rose further and became significantly higher compared to baseline within 48 h. Serum cystatin C remained significantly elevated at 48- and 72-h post-CPB. Conclusions: Processes that determine the serum concentrations of serum creatinine and cystatin C in the post-CPB period affect the two biomarkers differently, suggesting that the two are not interchangeable as diagnostic markers of glomerular filtration rate. Future studies are needed to examine if these discrepancies are related to differences in their production rates, in their ability to detect small changes in glomerular filtration rate, or to a combination of these, and to determine the effect of such differences on the diagnostic and prognostic accuracy of the two biomarkers.

UR - http://www.scopus.com/inward/record.url?scp=84890793999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890793999&partnerID=8YFLogxK

U2 - 10.1007/s11255-013-0403-5

DO - 10.1007/s11255-013-0403-5

M3 - Article

VL - 45

SP - 1597

EP - 1603

JO - International Urology and Nephrology

JF - International Urology and Nephrology

SN - 0301-1623

IS - 6

ER -